Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Detail)

v3.3.0.814
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Accounting Policies [Line Items]    
Percentage of tax benefit likely of being realized 50.00%  
Restricted Cash and Cash Equivalents $ 14.6  
Gain (Loss) on Sale of Assets and Asset Impairment Charges   $ 0.4
CB Pharma Acquisitions Corp [Member]    
Accounting Policies [Line Items]    
Fair Value, Assets Measured on Recurring Basis, Change in Unrealized Gain (Loss) 4.1  
Hercules Note Payble [Member]    
Accounting Policies [Line Items]    
Restricted Cash and Cash Equivalents 0.6  
Debt Instrument, Periodic Payment $ 14.0